Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2023-02-17 00:00:00 ET · period of report 2023-02-15 · accession 0001415889-23-002712 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-17 | 2023-02-15 | HALO | LaBrosse Nicole | SVP, CFO | M - OptEx | $0.00 | +1,254 | 7,118 | +21% | $0 |
| D | 2023-02-17 | 2023-02-15 | HALO | LaBrosse Nicole | SVP, CFO | F - Tax | $49.20 | -621 | 6,497 | -9% | -$30.6K |
| D | 2023-02-17 | 2023-02-15 | HALO | LaBrosse Nicole | SVP, CFO | M - OptEx | $0.00 | -1,254 | 2,508 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-15 | M | A | 1,254 | $0.00 | 7,118 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-15 | F | D | 621 | $49.20 | 6,497 | D | — | — | (F1) The reported disposition of 621 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations. |
| 3 | Derivative | Restricted Stock Units | 2023-02-15 | M | D | 1,254 | $0.00 | 2,508 | D | $0.00 · — to — | 1,254 Common Stock | (F2) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |